kyprolis-hcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Sitemap: | ||
Meta Tags
| Title | KYPROLIS® (carfilzomib) for Relapsed/Refractory Multiple |
| Description | Reach out to a KYPROLIS® Field Learn about KYPROLIS® (carfilzomib), a proteasome inhibitor used as a treatment for relapsed or refractory multiple myeloma. See Full Safety |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 54.186.217.87 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
kyprolis-hcp.com Valuation
|
US$10,444,287
Last updated: 2023-05-03 02:02:13
kyprolis-hcp.com has Semrush global rank of 1,013,406. kyprolis-hcp.com has an estimated worth of US$ 10,444,287, based on its estimated Ads revenue. kyprolis-hcp.com receives approximately 1,205,111 unique visitors each day. Its web server is located in United States, with IP address 54.186.217.87. According to SiteAdvisor, kyprolis-hcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$10,444,287 |
| Daily Ads Revenue | US$9,641 |
| Monthly Ads Revenue | US$289,227 |
| Yearly Ads Revenue | US$3,470,717 |
| Daily Unique Visitors | 80,341 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| kyprolis-hcp.com. | A | 299 | IP: 54.186.217.87 |
| kyprolis-hcp.com. | A | 299 | IP: 35.164.71.181 |
| kyprolis-hcp.com. | NS | 86400 | NS Record: ns-1290.awsdns-33.org. |
| kyprolis-hcp.com. | NS | 86400 | NS Record: ns-157.awsdns-19.com. |
| kyprolis-hcp.com. | NS | 86400 | NS Record: ns-1600.awsdns-08.co.uk. |
| kyprolis-hcp.com. | NS | 86400 | NS Record: ns-708.awsdns-24.net. |
| kyprolis-hcp.com. | MX | 300 | MX Record: 3 amgen-com.mail.protection.outlook.com. |
HtmlToTextCheckTime:2023-05-03 02:02:13
| INDICATION Indications KYPROLIS ® (carfilzomib) is indicated in combination with dexamethasone, or with lenalidomide plus dexamethasone, or with daratumumab plus dexamethasone, or with daratumumab plus hyaluronidase-fihj plus dexamethasone, or with isatuximab plus dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy. KYPROLIS ® is indicated as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy. ... Read More --> Prescribing Information Indications Important Safety Information References FAQ Connect with a Rep Visit Patient Site Prescribing Info Indications Efficacy DKd vs Kd study Study design Study results Kd once weekly study Study design Study results Kd vs Vd study Study design Study results Results by patient type KRd study Study design Study results Results by patient type Safety Safety: DKd vs Kd Study |
HTTP Headers
HTTP/1.1 403 Forbidden Server: awselb/2.0 Date: Mon, 25 Oct 2021 09:25:27 GMT Content-Type: text/html Content-Length: 118 Connection: keep-alive |
kyprolis-hcp.com Whois Information
Domain Name: KYPROLIS-HCP.COM Registry Domain ID: 1969938927_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-09-17T09:13:09Z Creation Date: 2015-10-19T18:03:07Z Registry Expiry Date: 2022-10-19T18:03:07Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1290.AWSDNS-33.ORG Name Server: NS-157.AWSDNS-19.COM Name Server: NS-1600.AWSDNS-08.CO.UK Name Server: NS-708.AWSDNS-24.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T13:15:11Z <<< |